Replies to post #195998 on Biotech Values

[DewDiligence]

(MNTA)—Astellas is the four-largest Japanese drug company (based on 2014 sales):

http://www.pmlive.com/top_pharma_list/japan_revenues

So the short answer to your questions is yes.